Forward Pharmaceuticals Co., Ltd.
Clinical trials sponsored by Forward Pharmaceuticals Co., Ltd., explained in plain language.
-
New hope for advanced breast cancer: experimental drug FWD1802 enters human trials
Disease control Recruiting nowThis study tests a new drug called FWD1802 in people with a common type of advanced breast cancer (ER+/HER2-). The goal is to find a safe dose and see if it can shrink tumors. About 99 women with cancer that has spread or cannot be removed by surgery will take part. The study has…
Phase: PHASE1, PHASE2 • Sponsor: Forward Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for advanced breast cancer: combination therapy trial launches
Disease control Recruiting nowThis study is for people with a common type of advanced breast cancer (ER-positive/HER2-negative) that cannot be removed by surgery or has spread. It tests a new drug called FWD1802 combined with other treatments to find the safest dose and see if it shrinks tumors. About 196 par…
Phase: PHASE1, PHASE2 • Sponsor: Forward Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC